The second batch of high-value medical consumables in shandong province was successfully completed in the provincial public resource trading platform on May 15. There are 488 enterprises participating in this centralized purchase, with a total of 28,094 products and more than 180,000 specifications. By the end of April, there were 633 second-tier medical institutions trading through the platform, with a purchase order of 472.6 billion yuan. 

 

It is known that high value medical consumables security requirement is high, the clinical usage, specifications, chaos, exist in the actual purchase price is on the high side, distribution problem such as slow, reflect the strong society. For solving the above problems, the provincial government to deploy was carried out by high value medical consumables centralized purchasing work at the provincial level, and organizations in 2014 completed the first batch of high value medical consumables centralized purchasing work. In concluded on the basis of the first batch of centralized purchasing work experience, in July 2015, the provincial public resources trading platform fully introduced market competition, using "double envelope" comprehensive evaluation method, the organization carries out the second batch of centralized purchasing work. Procurement of such three kinds of expanded to the vascular interventional vascular intervention, orthopedics, neurosurgery, electrophysiology, pacemakers, extracorporeal circulation and blood purification, etc. 10 categories, 802 varieties. 

 

One is that procurement prices have fallen sharply. The winning products from outside the province in the average price fell by 20.7%, compared with before the centralized purchasing of medical institutions in the province average purchase price fell by 21.5%, the people of reform have more sense and identity, social effect is better. 

 

Second, the procurement channel is transparent. In centralized purchasing, the high value medical consumables purchase and disorderly problem, through the centralized purchasing, the medical institution supplies trading network, transparent, sunlight, reducing the risk of illegal illegal events. 

 

Third, the formation of a benign competition mechanism has accelerated. Centralized purchasing to make market competition more fully, a large number of outstanding quality, good clinical effect, high cost performance products, effectively lead the steps of medical health industry innovation and development.